Engineers Gate Manager’s Oric Pharmaceuticals ORIC Stock Holding History

Engineers Gate Manager’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$694K	Buy	+64,052	New	+$581K	0.01%	1298
2026 Q1	–	Sell	-10,335	Closed	-$84.5K	–	2454
2025 Q4	$84.5K	Buy	+10,335	New	+$119K	﹤0.01%	1937
2025 Q1	–	Sell	-16,554	Closed	-$134K	–	2459
2024 Q4	$134K	Buy	+16,554	New	+$152K	﹤0.01%	1967
2022 Q3	–	Sell	-12,021	Closed	-$54K	–	1961
2022 Q2	$54K	Buy	+12,021	New	+$48K	﹤0.01%	1785

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Engineers Gate Manager's ORIC Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 64,052 shares worth $694K. The stake represents 0.01% of the portfolio and ranks #1298 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in ORIC as recently as Q4 2025.

Engineers Gate Manager first reported a position in ORIC in Q2 2022 and has held it in 4 quarters since. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Engineers Gate Manager held 64,052 shares of Oric Pharmaceuticals worth $694K as of Q2 2026.
Oric Pharmaceuticals was a new Engineers Gate Manager position in Q2 2026.
Oric Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1298 holding.
Engineers Gate Manager first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 4 quarters since.
181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.